Johan Wedell-Wedellsborg, Director at Y-Mabs Therapeutics, holds 4.56M shares in Y-Mabs Therapeutics (Ticker: YMAB). Most recently, Johan Wedell-Wedellsborg Bought $6,455 shares of Y-Mabs Therapeutics on Dec 12, 2023 for an estimated value of 44.22K.